Endurant Capital Management LP Rhythm Pharmaceuticals, Inc. Transaction History

Endurant Capital Management LP

  • $0
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$3.12 - $12.25 $330,071 - $1.3 Million
-105,792 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$6.13 - $12.24 $561,937 - $1.12 Million
-91,670 Reduced 46.42%
105,792 $1.22 Million
Q4 2021

Feb 14, 2022
BUY
$8.62 - $13.9 $1.7 Million - $2.74 Million
197,462 New
197,462 $1.97 Million

Others Institutions Holding RYTM

# of Institutions
192
Shares Held
67.3M
Call Options Held
834K
Put Options Held
78.6K
View Full List

About RHYTHM PHARMACEUTICALS, INC.

RYTM Quotes by TradingView
  • Ticker RYTM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,720,000
  • Market Cap $3.34B
  • Description
  • Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...
More about RYTM
Track This Portfolio

Track Endurant Capital Management LP Portfolio

Follow Endurant Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Endurant Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Endurant Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email